Nusinersen for Spinal Muscular Atrophy Type I with Chronic Respiratory Failure: A Retrospective Study in South Korea
CONCLUSION: Nusinersen is safe and effective in patients with SMA type I, even those with chronic respiratory failure and those on permanent ventilation. No significant adverse effects of nusinersen were observed.PMID:37992742 | DOI:10.3349/ymj.2023.0080
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Hui Jin Shin Ji-Hoon Na Hyunjoo Lee Young-Mock Lee Source Type: research
More News: Brain | Children | Neurology | Respiratory Medicine | South Korea Health | Spinal Muscular Atrophy | Study | Universities & Medical Training